发明授权
- 专利标题： Hepatitis C virus inhibitors
- 专利标题（中）： 丙型肝炎病毒抑制剂
-
申请号： US12755631申请日： 2010-04-07
-
公开(公告)号： US08143414B2公开(公告)日： 2012-03-27
- 发明人: Rico Lavoie , John A. Bender , Carol Bachand , Edward H. Ruediger , John F. Kadow
- 申请人： Rico Lavoie , John A. Bender , Carol Bachand , Edward H. Ruediger , John F. Kadow
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Pamela A. Mingo
- 主分类号： C07D513/14
- IPC分类号： C07D513/14 ; A61K31/426 ; A61K31/428 ; A61K31/429
摘要：
This disclosure concerns novel compounds of Formula (I) or Formula (II) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
公开/授权文献
- US20110098327A1 Hepatitis C Virus Inhibitors 公开/授权日：2011-04-28
信息查询
